These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20613548)

  • 41. Differential Impacts of HIV status on short-term fertility desires among couples in Rakai, Uganda.
    Song X; Grilo SA; Mathur S; Lutalo T; Ssekubugu R; Nalugoda F; Santelli JS
    PLoS One; 2019; 14(1):e0210935. PubMed ID: 30677068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Race, kidney disease progression, and mortality risk in HIV-infected persons.
    Alves TP; Hulgan T; Wu P; Sterling TR; Stinnette SE; Rebeiro PF; Vincz AJ; Bruce M; Ikizler TA
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2269-75. PubMed ID: 20876679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda.
    Ratmann O; Kagaayi J; Hall M; Golubchick T; Kigozi G; Xi X; Wymant C; Nakigozi G; Abeler-Dörner L; Bonsall D; Gall A; Hoppe A; Kellam P; Bazaale J; Kalibbala S; Laeyendecker O; Lessler J; Nalugoda F; Chang LW; de Oliveira T; Pillay D; Quinn TC; Reynolds SJ; Spencer SEF; Ssekubugu R; Serwadda D; Wawer MJ; Gray RH; Fraser C; Grabowski MK;
    Lancet HIV; 2020 Mar; 7(3):e173-e183. PubMed ID: 31953184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.
    Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S;
    HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiretroviral therapy-induced changes in plasma lipids and the risk of kidney dysfunction in HIV-infected men.
    Abraham AG; Li X; Jacobson LP; Estrella MM; Evans RW; Witt MD; Phair J
    AIDS Res Hum Retroviruses; 2013 Oct; 29(10):1346-52. PubMed ID: 23758574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
    Coresh J; Astor BC; Greene T; Eknoyan G; Levey AS
    Am J Kidney Dis; 2003 Jan; 41(1):1-12. PubMed ID: 12500213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of low estimated glomerular filtration rate, proteinuria, and associated risk factors among HIV-infected black patients using Cockroft-Gault and modification of diet in renal disease study equations.
    Longo AL; Lepira FB; Sumaili EK; Makulo JR; Mukumbi H; Bukabau JB; Mokoli VM; Kayembe PK; Nseka NM
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):59-64. PubMed ID: 21926635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals.
    Lucas GM; Atta MG; Zook K; McFall AM; Mehta SH; Fine DM; Stein JH; Schwartz GJ
    AIDS; 2016 Feb; 30(4):619-26. PubMed ID: 26558732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with decreased kidney function in HIV-infected adults enrolled in the MTCT-Plus Initiative in sub-Saharan Africa.
    Jao J; Lo W; Toro PL; Wyatt C; Palmer D; Abrams EJ; Carter RJ;
    J Acquir Immune Defic Syndr; 2011 May; 57(1):40-5. PubMed ID: 21266908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypertension, cardiovascular risk factors and antihypertensive medication utilisation among HIV-infected individuals in Rakai, Uganda.
    Sander LD; Newell K; Ssebbowa P; Serwadda D; Quinn TC; Gray RH; Wawer MJ; Mondo G; Reynolds S
    Trop Med Int Health; 2015 Mar; 20(3):391-6. PubMed ID: 25430847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CKD-EPI equation: A suitable Glomerular Filtration Rate estimate for drug dosing in HIV-infected patients.
    Gagneux-Brunon A; Botelho-Nevers E; Delanaye P; Lucht F; Frésard A; Cazorla C; Guglielminotti C; Fafin C; Mariat C; Moranne O
    Med Mal Infect; 2017 Jun; 47(4):266-270. PubMed ID: 28499765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort.
    Mayanja BN; Kasamba I; Levin J; Namakoola I; Kazooba P; Were J; Kaleebu P; Munderi P;
    AIDS Res Ther; 2017; 14():26. PubMed ID: 28484508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda.
    Prodger JL; Lai J; Reynolds SJ; Keruly JC; Moore RD; Kasule J; Kityamuweesi T; Buule P; Serwadda D; Nason M; Capoferri AA; Porcella SF; Siliciano RF; Redd AD; Siliciano JD; Quinn TC
    Clin Infect Dis; 2017 Oct; 65(8):1308-1315. PubMed ID: 28535179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors of chronic kidney disease in HIV-infected patients.
    Flandre P; Pugliese P; Cuzin L; Bagnis CI; Tack I; Cabié A; Poizot-Martin I; Katlama C; Brunet-François C; Yazdanpanah Y; Dellamonica P;
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1700-7. PubMed ID: 21566114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreasing HIV-1 seroprevalence in young adults in a rural Ugandan cohort.
    Mulder D; Nunn A; Kamali A; Kengeya-Kayondo J
    BMJ; 1995 Sep; 311(7009):833-6. PubMed ID: 7580488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical benefits of using inulin clearance and cystatin C for determining glomerular filtration rate in HIV-1-infected individuals treated with dolutegravir.
    Yukawa S; Watanabe D; Uehira T; Shirasaka T
    J Infect Chemother; 2018 Mar; 24(3):199-205. PubMed ID: 29150412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cross-Sectional and Longitudinal Performance of Creatinine- and Cystatin C-Based Estimating Equations Relative to Exogenously Measured Glomerular Filtration Rate in HIV-Positive and HIV-Negative Persons.
    Lucas GM; Atta MG; Zook K; Vaidya D; Tao X; Maier P; Schwartz GJ
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):e58-e66. PubMed ID: 33136753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An HIV-1 natural history cohort and survival times in rural Uganda.
    Morgan D; Malamba SS; Maude GH; Okongo MJ; Wagner HU; Mulder DW; Whitworth JA
    AIDS; 1997 Apr; 11(5):633-40. PubMed ID: 9108945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
    Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
    BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measuring the Impact of Antiretroviral Therapy Roll-Out on Population Level Fertility in Three African Countries.
    Marston M; Nakiyingi-Miiro J; Hosegood V; Lutalo T; Mtenga B; Zaba B;
    PLoS One; 2016; 11(3):e0151877. PubMed ID: 27015522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.